Attached files
| file | filename |
|---|---|
| S-1/A - S-1/A - Timber Pharmaceuticals, Inc. | a2224407zs-1a.htm |
| EX-4.2 - EX-4.2 - Timber Pharmaceuticals, Inc. | a2224407zex-4_2.htm |
| EX-4.4 - EX-4.4 - Timber Pharmaceuticals, Inc. | a2224407zex-4_4.htm |
| EX-1.1 - EX-1.1 - Timber Pharmaceuticals, Inc. | a2224407zex-1_1.htm |
| EX-10.16 - EX-10.16 - Timber Pharmaceuticals, Inc. | a2224407zex-10_16.htm |
| EX-10.17 - EX-10.17 - Timber Pharmaceuticals, Inc. | a2224407zex-10_17.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the use in this Amendment No. 1 to the Registration Statement on Form S-1 of our report dated April 20, 2015 relating to the consolidated financial statements of BioPharmX Corporation, which appears in such Registration Statement. We also consent to the reference of our firm under the heading "Experts" in such Registration Statement.
/s/ Burr Pilger Mayer, Inc.
San Jose, California
May 14, 2015